MOOGALI ARVIND: Open Payments
NPI 1730193665 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,908 in 107 payments from 23 companies in 2025. Trend: 2023 $2,190 · 2024 $2,527 · 2025 $1,908
Food & beverage: $1,908
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $381 |
| Lilly USA, LLC | 12 | $293 |
| ABBVIE INC. | 16 | $195 |
| AstraZeneca Pharmaceuticals LP | 8 | $163 |
| PFIZER INC. | 19 | $160 |
| Collegium Pharmaceutical, Inc. | 7 | $136 |
| HARMONY BIOSCIENCES LLC | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| Lundbeck LLC | 3 | $64 |
Products named: Ozempic, ZEPBOUND, Belbuca, JARDIANCE, Wegovy, ELIQUIS, WAKIX, QULIPTA.
Industry payments across NC — which companies pay providers there.
